The Effect of Diffusion Weighted Imaging Abnormalities on Outcomes in Patients with Spontaneous Intracerebral Hemorrhage (AHADWIICH)
Intracerebral hemorrhage (ICH) is the second most common cause of stroke and has been reported to account for between 8 to 15 percent of all strokes in high-income countries. ICH and ischemic strokes share many vascular risk factors, and patients can be at risk for having both happen at the same time. Diffusion-weighted imaging has the potential to detect small foci of neuronal injury, including secondary ischemic injury in patients with spontaneous ICH.
AHADWIICH is a prospective, blinded phase I clinical study funded by the American Heart Association that examines patients with spontaneous ICH in order to determine the presence and effect of DWI lesions on patient outcomes. Patients in acute setting will receive MRI to detect presence of lesions.
You may be eligible to participate in this study if you:
- Are an adult between 18 and 80 years of age
- Have a spontaneous intracerebral hemorrhage documented by CT scan
- Have no prior clinical history of stroke (i.e., subarachnoid hemorrhage, ICH or ischemic strokes)
You will be excluded from this study if you:
- Have a history of cancer, DVT or stroke
- Receive surgical intervention less than 48 hours from admission
- Have contraindications to receiving an MRI
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.